Obesity in the ageing man

Abstract As the population is ageing globally, both ageing and obesity are recognized as major public health challenges. The aim of this narrative review is to present and discuss the current evidence on the changes in body composition, energy balance and endocrine environment that occur in the agei...

Full description

Saved in:
Bibliographic Details
Published inMetabolism, clinical and experimental Vol. 62; no. 10; pp. 1341 - 1349
Main Authors Michalakis, K, Goulis, D.G, Vazaiou, A, Mintziori, G, Polymeris, A, Abrahamian-Michalakis, A
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.10.2013
Elsevier
Subjects
man
TNF
LOH
IR
ARC
CNS
BM
DHT
BT
T
PPT
SM
man
BMI
SS
BMR
T 3
T 4
PYY
RMR
LH
TT
TRH
FFM
WHO
MM
WHR
MS
TBW
TSH
CRH
DM2
WC
FT
HDL
NPY
GH
CCK
FT3
FT4
rT3
T3
T4
rT
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract As the population is ageing globally, both ageing and obesity are recognized as major public health challenges. The aim of this narrative review is to present and discuss the current evidence on the changes in body composition, energy balance and endocrine environment that occur in the ageing man. Obesity in the ageing man is related to changes in both body weight and composition due to alterations in energy intake and total energy expenditure. In addition, somatopenia (decreased GH secretion), late-onset hypogonadism (LOH), changes in thyroid and adrenal function, as well as changes in appetite-related peptides (leptin, ghrelin) and, most importantly, insulin action are related to obesity, abnormal energy balance, redistribution of the adipose tissue and sarcopenia (decreased muscle mass). A better understanding of the complex relationship of ageing-related endocrine changes and obesity could lead to more effective interventions for elderly men.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0026-0495
1532-8600
DOI:10.1016/j.metabol.2013.05.019